Evidence
Clinical studies · health economics · real-world data · geospatial access
A growing global health network
Questions become evidence. Evidence becomes better healthcare.
Clinicians, engineers, students, policymakers, communities, and innovators working across borders to generate the knowledge and tools healthcare decisions require.
50+associates
5+countries
60+reported active processes
2community pilots
One connected network
The people who understand the problem meet the people who can solve it.
microscopIA brings clinical, technical, academic, policy, innovation, and community perspectives into one governed system.
microscopIASolutions
AI · devices · decision tools · community pilots
Choose your pathway
One network. Three ways to create meaningful health impact.
Select the route that reflects what you want to accomplish.
01Doctors · Clinics · Hospitals
Convert clinical questions and data into decision-grade evidence.
Work with an end-to-end scientific team—from feasibility and protocol design to analysis, manuscript development, and journal submission.
Explore collaboration ↗02Students · Clinicians · Professionals
Join a real research project, not a simulated exercise.
Build practical research and publishing experience in a small, mentored team, with authorship determined by documented contribution.
View project pathways ↗03Open learning
Learn the methods behind better healthcare decisions.
Access workshops, videos, practical activities, and publication-oriented learning built around real research workflows.
Visit education ↗Decision intelligence for healthcare
From a clinical problem to evidence that can move systems.
microscopIA connects clinical expertise, engineering, analytics, and scientific publishing in one coordinated model.
Clinical evidence
Real-world studies, trials, evidence synthesis, and rigorous reporting.
Health economics
Cost-effectiveness, budget impact, net benefit, and investment decisions.
Geospatial intelligence
Travel-time access, service coverage, network design, and resource allocation.
AI & biomedical innovation
Clinical AI evaluation, imaging, medical devices, and translational prototypes.
Scientific publishing
Journal strategy, manuscript development, submission, and reviewer responses.
Research infrastructure
Embedded scientific capacity for healthcare facilities.
Evidence that builds technology
Collaboration today funds clinical support for tomorrow.
microscopIA reinvests in AI training, biomedical-device development, validation, and the research capacity needed to move prototypes toward responsible use.
Prototype footage · Not a cleared medical device
Device development · Prototype
AI-assisted automated microscope
A microscopy platform in development to support malaria and other light-microscopy workflows where specialist capacity is limited.
Clinical AI · In training and evaluation
Prioritising ROP referrals—without replacing clinicians.
The programme is training and evaluating AI to help neonatologists and neonatal nurses recognise examinations that may require priority referral to a pediatric ophthalmologist or retina specialist with appropriate training.
Decision boundaryThe system supports triage and prioritisation. It does not diagnose, prescribe, or replace clinical judgement. Diagnosis and care decisions belong to qualified healthcare professionals.
Explore responsible innovation Proof of collaboration
Finished work you can open, inspect, and cite.
A selected public sample. microscopIA currently reports 60+ research and innovation processes; this company-provided total is broader than the public catalogue.
01Open ↗02Open ↗03Open ↗04Open ↗
View the complete evidence portfolio ↗Original research · Public preprint
Prolonged travel time to intensive care in Colombia
Original research · Public preprint
Graft-specific travel-time accessibility and underserved zones in Colombia’s transplant system
Health economics · Public preprint
Economic evaluation of topical ketorolac and nepafenac prophylaxis for early-stage retinopathy of prematurity
Case report · Public preprint
Staged orthoplastic reconstruction of an 8-cm open Achilles tendon defect after crush trauma in a 7-year-old child
Institutional relationships
Credibility requires precise status—not borrowed prestige.
IMATONCOMÉDICA auna
Confirmed collaborationIMAT Oncomédica Auna
Clinical leadership, education, and research collaboration in Montería, Colombia.
PROCUREMENT
IN DEVELOPMENT
Vendor onboarding requestedIN DEVELOPMENT
MD Anderson Cancer Center
A direct institutional vendor-setup request has been received. Approval, contracting, endorsement, and formal partnership remain pending.
Scientific standards
Credibility is designed into the work.
Clear governance builds the confidence expected by clinicians, institutions, participants, journals, and patients.
Ethics and data governance
Projects proceed only with an appropriate legal, ethical, and data-use basis.
Authorship by contribution
Authorship and order reflect documented scientific contribution—not payment alone.
Transparent publication pathway
Journal strategy, open-access charges, review risk, and editorial independence are explained in advance.
Quality before volume
Feasibility, methods, data quality, reproducibility, and reporting guide every decision.
Leadership network
Clinical authority. Scientific depth. Global collaboration.
Dr. Agamenón Quintero Villarreal
President, Asociación Colombiana de Sociedades Científicas · Head of Education, IMAT Oncomédica Auna
Montería, Colombia
Critical care and healthcare policy
Dr. Joseph L. Nates
Deputy Department Chair · Patient Safety and Quality Officer, Critical Care Medicine, MD Anderson Cancer Center
Houston, Texas, USA
Oncologic critical care and international collaboration
Dr. Francisco Camargo
Head of Critical Care Medicine, Clínica Zayma
Montería, Colombia
Critical care, obstetric intensive care, and anesthesiology
Jorge Racedo
Founder and Head of the microscopIA Network
Geneva, Switzerland
Health systems engineering, economics, geospatial analysis, AI, and innovation
Start with the right pathway
Bring a clinical question, a dataset, or the ambition to contribute.
microscopIA will help determine whether collaboration, project participation, or education is the strongest next step.